Delhi End TB Summit 2018, 13-14 March 2018, New Delhi, India
The World Health Organization along with the Ministry of Health & Family Welfare, Govt of India, Stop TB Partnership and other partners organized a multicountry multiagency TB Summit in Delhi from 13-14 March 2018.
The meeting was also aimed to track progress to eliminate tuberculosis as the Member countries of WHO South-East Asia Region are committed to further intensify efforts to ensure rapid and concrete progress to End TB by 2030.
The inaugural session was held on 13 March at Vigyan Bhawan, Delhi and attended by Prime Minister of India along with cabinet and State Ministers of Health and Family Welfare. Other dignitaries gracing the occasion were Health Ministers from Indonesia and Nigeria, DG WHO, Regional Director WHO SEARO, Executive Director Stop TB Partnership and Executive Director, Global Fund. Prime Minister of India launched the TB free India Campaign and committed to end TB in the country by 2025.
Ministerial Meeting towards Ending TB in the South-East Asia, 15-16 March 2017, New Delhi, India
The South East Asia (SEA) Region of WHO is home to one fourth of the world’s population; however the region accounts for nearly half of the global burden in terms of new TB cases appearing each year. In 2015, there were an estimated 4.74 million new cases of TB and nearly 800 000 people died due to TB (and TB-HIV) in the Region. Total number of new cases notified to National TB programs of the SEA Region were only about 54% of the new cases. Six SEAR Member States are in the list of 30 high TB burden countries globally- Bangladesh, DPR Korea, India, Indonesia, Myanmar and Thailand. The estimated incidence of multi-drug-resistant and rifampicin resistant (MDR/RR-TB) in the Region is 200,000 out of which only 32,648 were started on treatment in 2015 or just around 16% of the incident cases. Extensively drug resistant TB had been reported by 6 countries in SEAR by 2015. An estimated 227,000 cases (4.7%) of the 4.7 million incident cases were HIV positive. With current level of efforts, the Region is achieving only 1.5-2% annual decline in incidence of TB which is grossly insufficient compared to the required decline of at least 10-15% if we are to reach the WHO End TB Strategy targets (aligned with the SDG goals).
In a recently concluded Ministerial Meeting from 15-16 March 2017, all 11 Members States signed a Call for Action towards ending TB in the SEA Region. The key highlights of call for action are - National Initiatives empowered by head of States; Ensure full funding for TB programmes; Universal access to high quality TB care in all sectors; Patient centered socio-economic support; Regional Innovation to Implementation fund; and Mobilize global resources
World TB Day 2016
In 2016 the United Nations has adopted the Sustainable Development Goals (SDGs) providing a new development framework for 2016-2030, replacing the 2000-2015 Millennium Development Goal (MDG) framework. Under Goal 3 of the SDGs specifically pertaining to health, target 3.3 states- By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, combat hepatitis, waterborne and other communicable diseases.
The WHO South-East Asia Region is home to 26% of the world’s population, but accounts for 46% of the global burden of TB incidence. In the Region in 2015 TB incidence was estimated around 4.7 million. Eliminating the disease in the Region is critical to ending the global TB epidemic.
Addressing the determinants of TB such as poverty and direct risk factors e.g, overcrowding and poorly ventilated living and working environment have to be shared by all stakeholders. Eliminating TB should take significant effort and requires effective operationalization of the END TB Strategy that includes political commitment, better financing system, universal access to high quality care, and poverty reduction strategies.
TB burden, 2015
46%The proportion of the global TB incidence in the RegionRefer to Pie chart
TB Mortality, 2015
710 000 TB deaths
and additional 74 000 deaths from TB-HIV coinfection in the Region
MDR/RR-TB incidence, 2015
34%The proportion of global estimates multidrug-resistant/rifampicin-resistant new cases from the RegionRefer to SEAR TB Annual Report 2016